Qube Research & Technologies (QRT)
NHI icon

Qube Research & Technologies (QRT)’s National Health Investors NHI Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NHI Stock Details NHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.78M Sell
42,322
-787
-2% -$57.8K ﹤0.01% 2145
2026
Q2 		$3.29M Sell
43,109
-386,438
-90% -$29.6M ﹤0.01% 1851
2026
Q1 		$34.7M Buy
429,547
+197,277
+85% +$16.4M 0.04% 581
2025
Q4 		$17.7M Sell
232,270
-33,778
-13% -$2.59M 0.02% 977
2025
Q3 		$21.2M Sell
266,048
-53,238
-17% -$3.98M 0.02% 866
2025
Q2 		$22.4M Buy
319,286
+147,591
+86% +$10.8M 0.02% 814
2025
Q1 		$12.7M Sell
171,695
-33,963
-17% -$2.4M 0.01% 982
2024
Q4 		$14.3M Buy
205,658
+96,755
+89% +$7.36M 0.02% 883
2024
Q3 		$9.15M Buy
108,903
+67,730
+165% +$5.22M 0.01% 1093
2024
Q2 		$2.79M Buy
41,173
+38,836
+1,662% +$2.49M ﹤0.01% 1491
2024
Q1 		$147K Sell
2,337
-20,602
-90% -$1.16M ﹤0.01% 3162
2023
Q4 		$1.28M Buy
22,939
+20,583
+874% +$1.09M ﹤0.01% 1780
2023
Q3 		$121K Buy
+2,356
New +$123K ﹤0.01% 2594
2023
Q2 		– Sell
-24,804
Closed -$1.28M – 2796
2023
Q1 		$1.28M Sell
24,804
-9,460
-28% -$516K 0.01% 1194
2022
Q4 		$1.79M Buy
34,264
+20,725
+153% +$1.14M 0.01% 986
2022
Q3 		$765K Buy
+13,539
New +$853K ﹤0.01% 1304
2022
Q2 		– Sell
-26,381
Closed -$1.56M – 2918
2022
Q1 		$1.56M Buy
+26,381
New +$1.5M 0.01% 934
2021
Q4 		– Sell
-22,586
Closed -$1.21M – 2830
2021
Q3 		$1.21M Buy
+22,586
New +$1.41M 0.02% 837
2018
Q4 		– Sell
-52
Closed -$4K – 686
2018
Q3 		$4K Sell
52
-948
-95% -$72.4K ﹤0.01% 1024
2018
Q2 		$74K Buy
+1,000
New +$70.7K 0.05% 380

Other funds holding NHI

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NHI Position: Q3 2026 in Review

Qube Research & Technologies (QRT) reduced its National Health Investors (NHI) stake by 1.8% in Q3 2026, selling an estimated $57.8K and leaving 42,322 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #2145.

Qube Research & Technologies (QRT) first reported a position in NHI in Q2 2018 and has held it in 20 quarters since. The position peaked at $34.7M in Q1 2026. 261 funds tracked by Wall St. Rank hold NHI as of Q3 2026.

  • Qube Research & Technologies (QRT) held 42,322 shares of National Health Investors worth $2.78M as of Q3 2026.
  • Qube Research & Technologies (QRT) sold 787 National Health Investors shares in Q3 2026, an estimated $57.8K.
  • National Health Investors made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2145 holding.
  • Qube Research & Technologies (QRT) first reported a position in National Health Investors in Q2 2018 and has held it in 20 quarters since.
  • Qube Research & Technologies (QRT)'s National Health Investors position peaked at $34.7M in Q1 2026.
  • 261 funds tracked by Wall St. Rank held National Health Investors as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.